New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
07:15 EDTEWEdwards Lifesciences shares should be bought on weakness, says Wells Fargo
After Edwards reported lower than expected U.S. Q4 Sapien revenue, Wells Fargo thinks that a large number of catalysts should cause the stock to outperform for the remainder of 2013. The firm maintains an Outperform rating on the stock.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 25, 2014
10:13 EDTEWHigh option volume stocks
Subscribe for More Information
06:34 EDTEWEdwards Lifesciences price target raised to $120 from $95 at Piper Jaffray
Piper Jaffray raised its price target for Edwards Lifesciences shares to $120 saying recent Transcatheter Aortic Valve Replacement market momentum is likely to continue. The firm keeps an Overweight rating on the stock.
September 18, 2014
09:19 EDTEWGeneration Investment reports 5.2% passive stake in Edwards Lifesciences

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use